Andren-SandbergA., IsacsonS.: Tissue Polypeptide Antigen in colorectal carcinoma. In: Clinical application of carcinoembryonic antigen assay. Excerpta Medica International Congress Series.439; 139 (1977).
2.
BazzocchiA., RonchiA., MatteucciM., PallottiG.: Valutazioni preliminari sull'impiego del TPA nello studio delle neoplasie del tratto genito-urinario. Aggiornamenti sul Tissue Polypeptide Antigen (TPA), da: Il TPA e gli altri markers tumorali, p. 63. Bologna 1983.
3.
BjörklundB.: Antigenicity of malignant and normal human tissues by gel diffusion techniques. Intern. Arch. Allergy, 8; 179 (1956).
4.
BjörklundB., LundbladG., BjörklundV.: Antigenicity of pooled human malignant and normal tissues by cytoimmunological technique: II. Nature of tumor antigen. Intern. Arch. Allergy, 12; 241 (1958).
5.
BjörklungB., BjörklundV., WiklundB., LundströmR., EkdahlP. H., HagbardL., KaijserK., EklundG., LuningB.: A human Tissue Polypeptide related to cancer and placenta: I. Preparation and properties; II. Assay technique; III. Clinical studies of 1483 individuals with cancer and other conditions. In: Immunological techniques for detection of cancer; by Bjorklung B., p. 133–187. Bonniers, Stockholm1973.
6.
BjörklundB., BjörklundV., LundströmR., EklundG.: Tissue Polypeptide Antigen (TPA) in human cancer defense responses. In: The reticuloendothelial system in health and disease: immunologic and pathologic aspects, by Friedman H., and Escobar M. R., p. 357–370. Plenum Press, New York1976.
7.
BjörklundB.: Review of the immunochemical and clinical significance of TPA. In: Protides of the biological fluids, by Peeters H., p. 505–512. Pergamon Press, Oxford1976.
BjörklundV., BjörklundB.: Localization of synthesis of TPA in normal malignant human tissues by immunohistological techniques. In: Protides of the biological fluids, by Peeters H., p. 229–232. Pergamon Press, Oxford1979.
10.
BjörklundB.: On the nature and clinical use of tissue polypeptide antigen (TPA). Tumor Diagn., 1; 9 (1980).
11.
GoldP., FreedmanS. O.: Specific Carcinoembryonic Antigen of the human digestive system. J. Exp. Med., 122; 467 (1965).
12.
HagbardL., SorbeB.: Preliminary experiences of TPA (Tissue Polypeptide Antigen) in cancer of the ovary. Läkartidningen, 75; 3433 (1978).
13.
JavadpourN.: Tumor markers in urologic cancer. Urology, 16; 127 (1980).
14.
LüthgensM., SchlegelG., EklundG., BjörklundB.: Correlation between activity in breast cancer and CEA, TPA and eighteen common laboratory procedures and the improvement by the combined use of CEA and TPA. Tumor Diagn., 2; 6 (1981).
15.
OehrP., AdolphsH. D., WustrowA.: Simltanbestimmung von CEA. TAG und TPA in Serum von Harnblasencarcinom-Patient: Analyse von Markerfrequenz und Markerunabhangigkeit unter Berucksichtigung von Tumorstadium, Malignitätsgrad und Krankheitsverlauf. Tumor Diagn2; 27 (1981).
16.
RosenS. W., WeintraubeB. D., VaitukaitisJ. L., SussmanH. H., HeishmanJ. M., MuggioF. M.: Placental proteins and their subunits as tumor markers. Ann. Intern. Med., 82; 7 (1975).
17.
WeintraubB. D., RosenS. W.: Competitive radioassays and specific tumor marker. Metabolism., 22; 1119 (1973).